CTI Science, Inc is a biotechnology firm based in Lexington, KY, dedicated to developing innovative health solutions. Their flagship product, Emeramide, is a lipophilic antioxidant that not only captures free radicals but also chelates heavy metals like mercury and lead, restoring normal function to the mitochondria and improving overall health. With ongoing clinical trials and preclinical studies for various indications, CTI Science is at the forefront of targeting the root causes of diseases and providing potential treatments for conditions such as COPD and even Covid-19.
EmeraMed Ltd, the parent company of CTI Science, is currently seeking drug approval from the European Medical Agency (EMA) and the United States Food and Drug Administration (FDA) for Emeramide. They are committed to improving health by harnessing the unique properties of Emeramide, which has shown exceptional safety and efficacy as a metal chelator and antioxidant. Despite the presence of counterfeit products in the market, CTI Science remains dedicated to their mission and continuously collaborates with regulatory authorities to take action against illegal sales. With a focus on research, clinical trials, and the future of health, CTI Science is poised to make a significant impact in the field of biotechnology.
Generated from the website